Mung Bean Extract for Health & Longevity

Created on 11/05/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Mung bean extract, a dietary supplement made from the bean's coat or protein, is used for blood sugar control, vessel health, and longevity. Small, short human studies of protein forms hint at better insulin levels, vessel function, and strength, with weak or borderline results versus comparison groups. Longevity claims for coat extracts rest on mice, roundworms, and cell studies. Risks appear modest at food-like amounts but are not systematically measured. (Full Review)

Protocol

Protein isolate for metabolic goals
3 g/day for 8 weeks
Split before breakfast and dinner; 1.5 and 6 g/day were tested for 4 weeks
Protein drink for vascular goals
10 or 15 g/day for 6 weeks
Mung bean protein in a drink taken before meals
Seed-coat (vitexin and isovitexin) extracts
No dose tested in healthy adults
One marketed label gives 240 mg coat extract daily without food
Time to effect
Endothelial function
6 weeks
Artery widening measured at trial end with mung bean protein
Insulin
8 weeks
Measured with protein isolate; no data describe earlier or longer timelines
Strength
8 weeks
Measured with mung bean protein in underactive vegetarians

Benefits

Contraindications
  • Confirmed mung bean allergy, or birch-pollen-related food allergy with Vig r 1 sensitization
  • Soy, peanut, or lupin allergy (unless testing excludes cross-reactivity)
  • Organ transplant recipients on tacrolimus or cyclosporine without trough-level monitoring
  • Untreated hypothyroidism or iodine deficiency, with seed-coat extracts (no human data)
Key Interactions
  • Tacrolimus: lower trough levels
  • Cyclosporine: lower exposure and falling trough levels
Theoretical (inferred from mechanism)
  • Glucose-lowering drugs (metformin, insulin): low blood sugar
  • ACE inhibitors and other antihypertensives (lisinopril, amlodipine): additive blood pressure lowering
  • Thyroid drugs (levothyroxine, methimazole): altered thyroid control
  • Other narrow-margin CYP3A substrates (sirolimus, everolimus): altered drug levels
  • Warfarin, with sprout-based products: reduced anticoagulation
  • Over-the-counter iron and zinc preparations (ferrous sulfate, zinc gluconate): lower mineral absorption
  • Glucose-lowering supplements (berberine, chromium): low blood sugar, mainly with concurrent diabetes drugs
  • Blood-pressure-lowering supplements (garlic extract, beetroot nitrate): lightheadedness
  • Fasting and very-low-carbohydrate diets: low blood sugar in people on glucose-lowering drugs

Risk & Side Effects

  • High:
  • Medium:
  • Low: Allergic reactions in birch-pollen- and legume-sensitized people; gastrointestinal discomfort; lowered tacrolimus and cyclosporine blood levels
  • Speculative: Thyroid hormone suppression; reduced iron absorption

Monitoring

Marker Target Why
Fasting insulin About 2.6–24.9 μU/mL Expected to change
HOMA-IR No established target; track change from own baseline Expected to change
Fasting glucose 70–99 mg/dL Low blood sugar check with glucose-lowering drugs
Triglycerides Below 150 mg/dL Expected to change
ALT About 7–56 U/L Expected to change
TSH About 0.4–4.0 mIU/L Safety check for antithyroid effect of vitexin
Ferritin About 24–336 ng/mL (men), 11–307 ng/mL (women) Safety check for reduced iron absorption
Tacrolimus or cyclosporine trough Transplant team's individual target Safety check (reductions were reported)
Mung bean or Vig r 1 specific IgE No established target; a positive result indicates sensitization Safety check for allergy before first use

Cadence: Baseline before starting; metabolic markers at 8 weeks, then every 6–12 months; TSH at 8 weeks, then annually; ferritin at 8–12 weeks, then annually, with seed-coat extracts; tacrolimus or cyclosporine trough levels 1–2 weeks after starting or stopping; fasting samples drawn in the morning after 10–12 hours without food

Qualitative Assessment

  • Digestive tolerance: bloating, cramping, or stool changes during the first two weeks
  • Oral itching or lip swelling after doses, an early sign of pollen-related allergy
  • Shakiness, sweating, or hunger between meals, signs of low blood sugar in people on glucose-lowering drugs
  • Strength progression in training logs for protein forms
  • Fatigue, cold intolerance, or weight gain, possible signs of reduced thyroid function